| Date | Title | Description |
| 23.09.2025 | NHS to Trial AI at ‘Unprecedented Scale’ | AI is to be trialled at ‘unprecedented scale’ across NHS screening services, the UK Government has announced, in a bid to boost early diagnosis and support the shift of care from analogue to digital.
Under the new plans, millions of patient... |
| 01.07.2025 | Belfast femtech startup Joii brings medical-grade period tracking to the masses | Dublin femtech startup Joii today launched its life-changing tech for how menstrual health is understood, monitored, and discussed in Ireland and beyond.
A world-first, Joii’s menstrual pad and mobile app measure period blood volume and clo... |
| 25.06.2025 | CUH lands double funding win for technology | Two cutting-edge medical technologies from Addenbrooke's to tackle brain injury are among 35 awarded a share of £3m from the National Institute for Health and Care Research (NIHR).
The projects are funded through the Invention for Innovatio... |
| 03.04.2025 | The Shadows of Cybercrime: How Cameroon's Web Developers Fuel Online Fraud | In the digital age, the internet is a double-edged sword. It connects us, but it also opens doors to deception. In Cameroon, a troubling trend has emerged. Web developers, skilled in technology, are inadvertently becoming the backbone of on... |
| 03.04.2025 | British medtech Calla Lily secures £1M for transformative progesterone delivery device | Calla Lily, a UK-based medtech who have created a device for pregnant women at risk of miscarriage has secured £1M in funding from the National Institute for Health and Care Research (NIHR). The device helps women undergoing early pregnancy... |
| 28.02.2025 | Presymptom Health secures £200K for fast infection detection technology | UK medtech Presymptom Health has secured £200,000 in additional grant funding to speed up its AI-driven infection detection technology, cutting test times to just 40-60 minutes.
Presymptom Health was established to exploit IP developed by s... |
| 11.02.2025 | Medidata Integrates UK Costing Data into Grants Manager, Streamlining Clinical Trial Budgeting | What You Should Know:
– Medidata, a Dassault Systèmes brand and a leading provider of clinical trial solutions, today announced the integration of data from the UK interactive Costing Tool (iCT) into its Grants Manager platform.
– The colla... |
| 06.02.2025 | AI and Breast Cancer: A New Dawn in Early Detection | The UK is stepping into a new era of healthcare. A groundbreaking trial is set to screen 700,000 women for breast cancer using artificial intelligence. This initiative, backed by £11 million from the government, aims to revolutionize how we... |
| 04.02.2025 | “World-leading” AI Trial to Screen 700K UK Women for Breast Cancer | The UK’s Department of Health and Social Care (DHSC) has announced that nearly 700,000 women across the country will take part in a “world-leading” trial to test how AI tools can be used to catch breast cancer cases earlier.
As the governme... |
| 30.12.2024 | MintNeuro – Secures £1m investment in latest capital raise | We are delighted to announce our investment in MintNeuro, an Imperial College London spinout and innovative startup at the dynamic intersection of neurotechnology and semiconductors.
London, UK, November 12 2024 – MintNeuro, a pioneer of sc... |
| 11.12.2024 | Grants and cash prizes for Swiss innovators |
A jury of 40 experts has nominated Chainstaff as the HR Start-up of the Year 2024 as part of the HR Excellence Award. Held in Berlin, the award recognises outstanding ideas, projects and campaigns in human resource management. The Swiss st... |
| 20.11.2024 | The quantum revolution: Five ways quantum will transform everyday life | Our world is gripped by uncertainty. From economic volatility to the climate crisis, businesses and individuals alike are navigating a landscape marred by unpredictability. As the World Economic Forum warns in its most recent global risk re... |
| 21.10.2024 | Cambridge and GSK announce new five-year collaboration aiming for improved outcomes for patients with hard-to-treat kidney and respiratory diseases | The ambition of the partnership is to treat immune-related diseases more precisely with existing therapies and to rapidly develop new ones.
The Cambridge-GSK Translational Immunology Collaboration (CG-TIC) combines University and GSK expert... |
| 16.10.2024 | Project Core: An Initiative for Community-Focused Oral Health Research for Equity Launched | New Delhi, Delhi, India
Oral diseases are among the most prevalent diseases globally and have serious health and economic burdens, greatly reducing quality of life. The most prevalent and consequential oral diseases globally are dental cari... |
| 11.10.2024 | Teesside University: A Beacon for Mental Health Initiatives | In a world where mental health is often overshadowed, Teesside University stands tall. Recently, it received the Student Minds University Mental Health Charter Award. This accolade is not just a badge of honor; it’s a testament to the unive... |
| 10.10.2024 | Innovative mental health research partnership launches to study new therapies | People across Cambridgeshire and Peterborough with severe mental health conditions now have the opportunity to take part in local groundbreaking clinical trials, to assess if empathogens and psychedelics can help people with treatment-resis... |
| 10.10.2024 | Multimillion-pound boost for regional mental health research | Multimillion-pound boost for regional mental health research
Thu, Oct 10, 2024 10:40 CET Report this content
Teesside University has secured a prestigious National Institute for Health and Care Research (NIHR) Mental Health Research Leader ... |
| 06.08.2024 | Шесть способов позаботиться о здоровье мозга, когда вам ещё нет 40 | Деменция не является неизбежным следствием старения. Считается, что около 40 % случаев деменции можно предотвратить (или хотя бы отсрочить), изменив некоторые привычки образа жизни.
В настоящее время известно 12 модифицируемых факторов риск... |
| 31.07.2024 | A New Dawn for Alzheimer's Treatment: The Promise of GLP-1 Drugs | In the realm of Alzheimer's research, a new player has emerged, and it’s wearing the familiar coat of a diabetes medication. Liraglutide, a glucagon-like peptide-1 (GLP-1) agonist, has shown potential in slowing cognitive decline, igniting ... |
| 30.07.2024 | GLP-1 DRUG LIRAGLUTIDE MAY PROTECT AGAINST DEMENTIA | Key Takeaways
A GLP-1 agonist — the class of drugs shown to help with diabetes and weight loss and reduce the risk of heart disease — also may protect the brain.
In a Phase 2b trial, liraglutide appears to reduce shrinking in the parts of t... |
| 19.07.2024 | «Умные» часы стали использовать для медицинских исследований людей с сердечно-сосудистыми заболеваниями | Мониторинг частоты сердечных сокращений и физической активности с помощью доступных в продаже носимых устройств оказался полезен для сравнения эффективности двух методов лечения фибрилляции предсердий и сердечной недостаточности. В исследов... |
| 20.06.2024 | 77-year-old with Parkinson's all set to walk 120-kilometre stretch of Hadrian's Wall to raise awareness around the importance of exercise - at the point of diagnosis | Trevor Elliott is one of six Parkinson's patients who helped co-design a digital intervention with a specialist physiotherapist as part of a feasibility study for Addenbrooke's Hospital - highlighting the importance of early exercise for Pa... |
| 03.04.2024 | Researchers report findings to improve medication management in palliative care | A study led by CPFT experts reviewing how medications are used in palliative care to support patients in the community has been published in a leading international nursing journal.
Injectable medications prescribed in anticipation - just i... |
| 15.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx™ Electroencephalogram (EEG) Study for Early Detection of Alzheimer’s Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer’s Dementia
BELFAST, Northern Ireland and CAMBRIDGE, Mass.—March 14, 2024— Cumulus Neuroscience (Cumulus; The Company), a global digital health com... |
| 15.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx™ Electroencephalogram (EEG) Study for Early Detection of Alzheimer’s Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer’s Dementia
BELFAST, Northern Ireland and CAMBRIDGE, Mass.—March 14, 2024— Cumulus Neuroscience (Cumulus; The Company), a global digital health company focu... |
| 14.03.2024 | Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia | NIHR-Funded Study Represents the Largest of its Kind Conducted to Date in Alzheimer's Dementia.
Cumulus Neuroscience today announced the enrollment of the first patient in a major research collaboration with the Universities of Bath and Bri... |
| 02.01.2024 | Senior NHS Trust staff amongst first recruits to join new BioResource Centre in Sheffield at launch event | More than 250,000 volunteers across England have already signed up to the national NIHR BioResource, with the new Sheffield BioResource Centre aiming to recruit 800 people a year.
Researchers have set up a Sheffield BioResource Centre as pa... |
| 23.06.2023 | Startups seek growth opportunities abroad | |
| 03.03.2023 | Mendelian's rare disease case load AI secures £1.4 million grant award | UK-based Mendelian is preparing further trials of its AI case-finding tool for diagnosing rare diseases at scale after being awarded $1.4 million from a national health innovation grant making body.
The Artificial Intelligence in Health and... |
| 02.03.2023 | AI Could Revolutionise Organ Transplant System | A new method using Artificial Intelligence (AI) to assess the quality of organ donations could revolutionise the transplant system, potentially saving lives and tens of millions of pounds.
The National Institute for Health and Care Research... |
| 03.06.2022 | CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded access | The CDC said Friday that one monkeypox patient in the US so far has been treated with SIGA Technologies’ tecovirimat, known commercially as TPOXX, which is an antiviral agent from the strategic national stockpile with ant... |
| 25.11.2021 | London man receives “world’s first” 3D printed prosthetic eye | A London man has reportedly become the first person in the world to be fitted with a 3D printed prosthetic eye.
Steve Verze received the eye today at Moorfields Eye Hospital in Finsbury, London, which provides a more realistic look than a t... |
| 09.11.2021 | The Valneva COVID-19 vaccine: Why it might be a game-changer | Since their inception and rollout, COVID-19 vaccines have changed the course of the pandemic. Prior to the vaccines, we relied on social distancing measures to help reduce the spread of the virus and a handful of imperfect treatment options... |
| 10.10.2021 | World Mental Health Day: Help to improve mental health care and treatments with CPFT | World Mental Health Day: Help to improve mental health care and treatments with CPFT
10-10-2021
On World Mental Health Day today (10 October), Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) is calling for more volunteers to tak... |
| 21.09.2021 | Join CPFT research making a difference for dementia | Join CPFT research making a difference for dementia
21-09-2021
On World Alzheimer’s Day today (21 September) dementia researchers at Cambridgeshire and Peterborough NHS Foundation Trust (CPFT) are calling for volunteers to join studies to l... |
| 29.06.2021 | IP : Navenio Ltd - Navenio Awarded Government Funding for its Hospital Workforce AI Platform | Navenio is proud to announce that it is one of 38 organisations to secure funding in the latest round of the Artificial Intelligence in Health and Care Award. The AI Award will make £140 million available over four years to accelerate the t... |
| 22.06.2021 | UK Healthcare Scaleup Navenio Secures Government Funding for its Hospital Workforce AI Platform | Navenio backed by NHSX to boost patient flow in NHS hospitals and help teams get back to capacity
Investment will allow Navenio to help transform multiple NHS sites with its innovative AI and location-based solution enabling “right person, ... |
| 22.04.2021 | EIT Health supported Optellum in AI world-first |
Optellum, an Oxford-based lung health technology company, which has been supported by EIT Health, is marking a world’s-first in achieving FDA clearance for the application of artificial intelligence (AI) decision support in lung cancer di... |
| 30.03.2021 | BERGENBIO ASA
BERGENBIO : ANNOUNCES STOPPED RECRUITMENT TO THE BEMCENTINIB ARM IN UK ACCORD COVID PLATFORM TRIAL | Bergen, Norway, 30 March 2021 - BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, announces that recruitment to the bemcentinib arm of the ... |
| 09.02.2021 | electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Reduce Ileus After Major Colorectal Surgery | UK-based study enrolled forty subjects and was undertaken to explore the safety and feasibility of self-administered non-invasive vagus nerve stimulation (nVNS) to treat ileus after major colorectal surgery |
| 13.11.2020 | ‘Long-COVID’ in our community – new call for research proposals | ‘Long-COVID’ in our community – new call for research proposals
13-11-2020
Up to £20 million is available for new research projects which aim to understand and address the longer-term physical and mental health effects of COVID-19 in non-ho... |
| 19.10.2020 | New global health research to reduce the impacts of COVID-19 | New global health research to reduce the impacts of COVID-19
19-10-2020
As COVID-19 continues to impact the lives and wellbeing of people around the globe, the National Institute for Health Research (NIHR), in partnership with UK Research a... |
| 30.09.2020 | Twelve things we know about Covid-19, thanks to health data research | Twelve things we know about Covid-19, thanks to health data research
30-09-2020
‘Twelve things we know about Covid-19, so far’, published by Health Data Research UK (HDRUK) demonstrates the absolute necessity for timely, secure access to he... |
| 15.09.2020 | New study to trial inhaled COVID-19 vaccines | New study to trial inhaled COVID-19 vaccines
15-09-2020
A new clinical study will explore the effects of administering COVID-19 vaccines as inhaled airborne droplets – similar to how inhaled asthma medications are delivered – rather than by... |
| 01.07.2020 | Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19 | Preliminary trial results find antiviral drug lopinavir/ritonavir does not reduce death in hospitalised patients with COVID-19
01-07-2020
The ‘RECOVERY’ trial has released preliminary results showing lopinavir/ritonavir, an antiviral drug c... |
| 17.06.2020 | Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19 | Preliminary trial results find dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19
17-06-2020
The ‘RECOVERY’ trial has released preliminary results showing low-cost dexamethasone reduces de... |
| 16.06.2020 | UKRI and NIHR move to new phase of COVID-19 research funding | UKRI and NIHR move to new phase of COVID-19 research funding
16-06-2020
The NIHR/UKRI COVID-19 rapid response initiative was established in February to address urgent needs in the face of the growing pandemic.
The Medical Research Council (... |
| 08.05.2020 | New call for research on the risk factors, transmission and prevalence of coronavirus | New call for research on the risk factors, transmission and prevalence of coronavirus
08-05-2020
A new call for research proposals on the risk factors, transmission and prevalence of the COVID-19 virus SARS-CoV-2, has been launched by UK Re... |
| 30.04.2020 | AstraZeneca joins UK Government’s ACCORD trial platform | AstraZeneca joins UK Government’s ACCORD trial platform
30-04-2020
AstraZeneca is joining forces with public research bodies and academic institutions as part of a UK government-led initiative to speed up the development of medicines to tre... |
| 20.04.2020 | Government launches Vaccine Taskforce to combat coronavirus | Government launches Vaccine Taskforce to combat coronavirus
20-04-2020
A new Vaccine Taskforce will drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine.
Rapid development and production of a co... |
| 20.04.2020 | Government launches Vaccine Taskforce to combat coronavirus | A new Vaccine Taskforce will drive forward, expedite and co-ordinate efforts to research and then produce a coronavirus vaccine.
Rapid development and production of a coronavirus vaccine will be driven by a new government-led Vaccine Taskfo... |
| 02.07.2019 | Cambridge University Hospitals revealed as country’s top performing trust for increasing research | Cambridge University Hospitals revealed as country’s top performing trust for increasing research
02-07-2019
Cambridge University Hospitals NHS Foundation Trust (CUH) has been revealed as England’s top performing trust for increasing resear... |
| 16.04.2019 | NIHR Brain Injury MedTech Co-operative: Seedcorn Competition 2019 now open | NIHR Brain Injury MedTech Co-operative: Seedcorn Competition 2019 now open
16-04-2019
The National Institute of Health Research (NIHR) Brain Injury MedTech Co-operative is pleased to launch the Seedcorn Funding Competition 2019.
Application... |
| 15.04.2019 | NIHR Brain Injury MedTech Co-operative: Seedcorn Competition 2019 now open! | NIHR Brain Injury MedTech Co-operative: Seedcorn Competition 2019 now open!
15-04-2019
The National Institute of Health Research (NIHR) Brain Injury MedTech Co-operative is pleased to launch the Seedcorn Funding Competition 2019.
Applicatio... |
| 26.09.2018 | Urine liquid biopsies could help monitor bladder cancer treatment | Urine liquid biopsies could help monitor bladder cancer treatment
26-09-2018
Scientists have shown for the first time that immune cells in the urine of bladder cancer patients accurately reflect those in the tumour environment, according to... |
| 18.05.2018 | NHS research takes the pressure off for Cambridge accountant | This weekend could see a rise in blood pressure for certain wedding goers and footballers but, for some, high blood pressure can be an everyday concern. However, a new study led by Cambridge University Hospitals aims to help patients with t... |
| 18.05.2018 | NHS research takes the pressure off for Cambridge accountant | NHS research takes the pressure off for Cambridge accountant
18-05-2018
This weekend could see a rise in blood pressure for certain wedding goers and footballers but, for some, high blood pressure can be an everyday concern. However, a new ... |
| 28.02.2018 | Retired Minister from Cambridge takes part in rare cancer trial | Retired Minister from Cambridge takes part in rare cancer trial
28-02-2018
A retired Methodist Minister from Cambridge is taking part in two rare disease trials in the hope that he can help other patients and the NHS in the future.
Today (F... |
| 28.02.2018 | Retired Minister from Cambridge takes part in rare cancer trial | A retired Methodist Minister from Cambridge is taking part in two rare disease trials in the hope that he can help other patients and the NHS in the future.
Today (February 28th) is Rare Disease Day
Stephen Burgess, 68, was diagnosed with a... |
| 20.06.2017 | Major award for Cambridge researcher takes prostate biopsy device into clinical application | Major award for Cambridge researcher takes prostate biopsy device into clinical application
20-06-2017
Researchers in Cambridge have secured funding of nearly £800,000 from the NIHR Invention for Innovation (i4i) programme to take a novel t... |
| 20.06.2017 | Major award for Cambridge researcher takes prostate biopsy device into clinical application | Researchers in Cambridge have secured funding of nearly £800,000 from the NIHR Invention for Innovation (i4i) programme to take a novel test for prostate cancer from a prototype to a CE-marked device for clinical application.
Add This Share... |
| 02.02.2017 | Tigerspike partners with the NIHR CRN to create mobile technology to streamline medical research processes | Tigerspike develops iPhone app using ResearchKit for the NIHR CRN to simplify clinical research projects
LONDON, UK, 2 February, 2017 - Tigerspike, a global digital products company has partnered with the National Institute for Health Resea... |
| 13.01.2016 | New hope for people who suffer with IBD with the launch of a major new research resource | New hope for people who suffer with IBD with the launch of a major new research resource
13-01-2016
People with Crohn’s Disease and Ulcerative Colitis are being asked to take part in a nationwide genetic database to help develop new treatme... |
| 02.09.2014 | Is silk the right road for eczema treatment? | Is silk the right road for eczema treatment?
02-09-2014
Cambridge University Hospitals is taking part in a landmark study on eczema in children, to establish whether silk clothing is effective in treating the condition.
It’s still unclear w... |
| 18.10.2013 | Scientists discover genetic disease which causes recurrent respiratory infections | Scientists discover genetic disease which causes recurrent respiratory infections
18-10-2013
Cambridge scientists have discovered a rare genetic disease which predisposes patients to severe respiratory infections and lung damage. Because th... |
| 11.01.2010 | Innovative new web interface improves access to UK's largest free online life sciences resource - beta.ukpmc.ac.uk | Helping researchers access and exploit over 1.7 million full-text, peer reviewed biomedical research articles and over 19 million other life science research papers, on 12 January the British Library will showcase a whole range of new searc... |
| - | How to address healthcare’s climate emergency | Is sustainability in healthcare the missing piece in the climate jigsaw? While the focus over the last few years has been on the corporate sector going green, have we all missed the opportunities that are emerging as the global healthcare c... |
| - | Omicron: Less severe, but still dangerous | Globally, Omicron is becoming the most frustrating good news/bad news story of the moment. As we learn more about the coronavirus variant, the information and the risk it poses keeps changing. That is to be expected with any novel disease o... |
